Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 235.00
Bid: 235.00
Ask: 245.00
Change: 3.00 (1.29%)
Spread: 10.00 (4.255%)
Open: 240.00
High: 240.00
Low: 235.00
Prev. Close: 232.00
PCA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

4 May 2017 07:00

RNS Number : 1170E
Palace Capital PLC
04 May 2017
 

 

 

 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

Palace Capital plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

Type 1 disclosure as per the Transparency Directive II Regulation

ü

3. Full name of person(s) subject to thenotification obligation:

Schroders plc

4. Full name of shareholder(s)  (if different from 3.):

Schroders plc & Schroder Investment Management Limited

5. Date of the transaction and date onwhich the threshold is crossed orreached:

02.05.17

6. Date on which issuer notified:

03.05.17

7. Threshold(s) that is/are crossed orreached:

From 12% - 11%

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary

 

GB00BF5SGF06

3,063,723

3,063,723

3,016,223

N/A

3,016,223

N/A

11.993%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,016,223

11.993%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

Schroder Investment Management Limited 3,016,223 11.993%

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

The shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements. This disclosure has been calculated based on issue share capital amount 25,150,692.

14. Contact name:

 

Shaheen Hussain

15. Contact telephone number:

 

020 7658 7941

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAXSDEFFXEFF
Date   Source Headline
14th Feb 20237:00 amRNSIndustrial property disposal
6th Feb 20237:00 amRNSShare Buyback
22nd Dec 20227:00 amRNSDisposals and Debt Position Update
25th Nov 20224:40 pmRNSSecond Price Monitoring Extn
25th Nov 20224:35 pmRNSPrice Monitoring Extension
24th Nov 20227:00 amRNSInterim Results
20th Oct 202212:03 pmRNSDirector Dealing
18th Oct 20223:49 pmRNSHolding(s) in Company
12th Oct 20227:00 amRNSTrading Update
15th Sep 20227:00 amRNSDividend Declaration
18th Aug 20222:51 pmRNSDirector Dealing
12th Aug 20227:00 amRNSBoard change
2nd Aug 20227:00 amRNSBoard change
29th Jul 20223:18 pmRNSResult of AGM
28th Jul 20221:39 pmRNSHolding(s) in Company
20th Jul 20226:04 pmRNSDirector Dealing
19th Jul 20227:00 amRNSFurther Update on Strategy and Changes to Board
15th Jul 20224:27 pmRNSHolding(s) in Company
13th Jul 202211:58 amRNSHolding(s) in Company
12th Jul 20223:36 pmRNSHolding(s) in Company
12th Jul 20229:50 amRNSHolding(s) in Company
12th Jul 20227:00 amRNSTransaction in Own Shares
4th Jul 20227:01 amRNSCommencement of share buyback
4th Jul 20227:00 amRNSUpdate on Strategy
28th Jun 202210:27 amRNSAnnual Report and Notice of Annual General Meeting
14th Jun 20222:10 pmRNSDividend Declaration
14th Jun 20227:01 amRNSResults for the year ended 31 March 2022
14th Jun 20227:00 amRNSBoard Change
1st Jun 20225:04 pmRNSTotal Voting Rights
6th Apr 20227:00 amRNSTrading update and dividend increase
25th Mar 20229:10 amRNSHolding(s) in Company
16th Mar 20223:58 pmRNSHolding(s) in Company
15th Mar 20222:03 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSDividend Declaration and Market Update
14th Mar 20229:46 amRNSHolding(s) in Company
3rd Mar 20227:00 amRNSPalace Capital exceeds disposal strategy targets
20th Jan 20224:40 pmRNSSecond Price Monitoring Extn
20th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Jan 20227:00 amRNSAcquisition of Maidenhead office building
20th Dec 20217:00 amRNSDisposal strategy nears completion
16th Dec 20217:00 amRNSAppointment of new Chairman
15th Dec 202110:46 amEQSHardman & Co Research: Hardman & Co Video | Analyst interview Q&A with Mike Foster on Palace Capital (PCA) | Interim results - ammunition for major dividend rises
9th Dec 20217:00 amRNSLetting of office space at Hudson Quarter, York
6th Dec 20217:00 amRNSSale of Staines Office Building
3rd Dec 202112:40 pmEQSHardman & Co Research : Palace Capital (PCA) - Interim results: ammunition for major dividend rises
29th Nov 20217:00 amRNSDisposal strategy continues with Aldershot sale
18th Nov 20217:00 amRNSDirector Dealing
17th Nov 20211:04 pmRNSINVESTOR PRESENTATION
16th Nov 20217:00 amRNSInterim Results
12th Nov 202110:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.